Tadimeti Rao, Ph.D.

Tadimeti Rao (Rao), Ph.D., is the Chief Scientific Officer at Design Therapeutics and has over thirty years of drug discovery and development experience. He participated in highly matrixed drug discovery programs at Pfizer, Merck, Auspex, Kalypsys, J&J, and most recently at Vividion, which delivered novel chemical entities for clinical evaluation in Neuroscience, Immunology-Inflammation, Metabolic Diseases and Oncology. He received his Ph.D. in Neuroscience from the University of Alberta, Canada and conducted post-doctoral research at Novartis. He is a licensed Pharmacist (RPh), Diplomate of American Board of Toxicology (DABT), and Diplomate of Safety Pharmacology (DSP).